US8637553B2 discloses omega-carboxyaryl diphenyl urea derivatives as potent inhibitors of PDGFR, VEGFR, RAF, and p38 kinase to treat cancer, inflammatory diseases, and osteoporosis. This evidence concerns the gene PDGFRB and cancer.